Coronavirus: India says may not need to vaccinate entire population to control Covid-19

Men ride on a motorbike past a supply truck of India's Serum Institute, the world's largest maker of vaccines, which is working on a vaccine against the coronavirus disease (COVID-19) in Pune, India, May 18, 2020.

Mumbai - World Health Organization experts have pointed to a 65%-70% vaccine coverage rate as sufficient to reach population immunity.

By Reuters

Published: Tue 1 Dec 2020, 8:14 PM

Last updated: Tue 1 Dec 2020, 9:42 PM

India may not need to vaccinate all of its 1.3 billion people if it manages to inoculate a critical mass and break the transmission of the coronavirus, senior government officials said on Tuesday.

Indian Prime Minister Narendra Modi, who toured the facilities of three vaccine makers over the weekend, has emphasised the importance of a vaccine to rein in Covid-19.

Advertising

Also read: Coronavirus: When and which Covid-19 vaccines are likely to be available in Asia

Indian think tank lauds UAE employment strategy, predicts post-Covid economic recovery in GCC

Covid-19: Indian lawmaker Kiran Maheshwari dies after testing positive for coronavirus

In October, he said that the government was preparing to reach every single citizen as soon as a vaccine was ready.

World Health Organization experts have pointed to a 65 per cent-70 per cent vaccine coverage rate as sufficient to reach population immunity.

"The government has never spoken about vaccinating the entire country," Rajesh Bhushan, the top bureaucrat in India's federal health ministry, told a news conference on Tuesday without reference to Modi.

India currently has the world's second-highest number of coronavirus infections, behind only the United States, with 9.46 million cases and 137,621 deaths.

India recorded 31,118 new coronavirus cases on Tuesday, the lowest daily tally since Nov. 17, data from the health ministry showed.

"...If we are able to vaccinate a critical mass of people, and break that virus transmission, then we may not have to vaccinate the entire population," Balram Bhargava, Director General of the state-run Indian Council Of Medical Research, said at the press briefing.

India's plan to roll out a Covid-19 shot in the first few months of 2021 wouldn't be impacted by an alleged adverse reaction during AstraZeneca's Covid-19 vaccine trial, Bhushan said.

A 40-year-old Indian man said in a complaint over the weekend that he had suffered serious “neurological and psychological” symptoms after receiving the vaccine in a trial being run by the British drugmaker’s partner, Serum Institute of India.

The incident is currently under investigation.